Ramsay, Stattman, Vela & Price, Inc. Abbott Laboratories Transaction History

Ramsay, Stattman, Vela & Price, Inc.

$525 Million
Q3 2024

A detailed history of Ramsay, Stattman, Vela & Price, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Ramsay, Stattman, Vela & Price, Inc. holds 104,749 shares of ABT stock, worth $12.1 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares

104,749

Previous 106,734 1.86%

Holding current value

$12.1 Million

Previous $11.1 Million 7.68%

% of portfolio

2.28%

Previous 2.14%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$100.07 - $118.13 $198,638 - $234,488	-1,985 Reduced 1.86%	104,749 $11.9 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $37,673 - $42,052	-374 Reduced 0.35%	106,734 $11.1 Million
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $225,720 - $249,298	-2,061 Reduced 1.89%	107,108 $12.2 Million
Q4 2023 Feb 01, 2024	SELL	$90.19 - $110.4 $157,020 - $192,206	-1,741 Reduced 1.57%	109,169 $12 Million
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $166,508 - $199,782	-1,743 Reduced 1.55%	110,910 $10.7 Million
Q2 2023 Jul 31, 2023	SELL	$100.78 - $112.29 $68,933 - $76,806	-684 Reduced 0.6%	112,653 $12.3 Million
Q1 2023 Apr 28, 2023	BUY	$96.86 - $114.01 $67,802 - $79,807	700 Added 0.62%	113,337 $11.5 Million
Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $60,838 - $71,372	-640 Reduced 0.56%	112,637 $12.4 Million
Q3 2022 Oct 28, 2022	SELL	$96.76 - $112.03 $37,542 - $43,467	-388 Reduced 0.34%	113,277 $11 Million
Q2 2022 Aug 04, 2022	BUY	$102.07 - $123.37 $44,604 - $53,912	437 Added 0.39%	113,665 $12.4 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $5,244 - $6,395	-46 Reduced 0.04%	113,228 $13.4 Million
Q4 2021 Jan 24, 2022	SELL	$115.53 - $141.46 $69,433 - $85,017	-601 Reduced 0.53%	113,274 $15.9 Million
Q3 2021 Oct 29, 2021	SELL	$116.66 - $129.06 $49,463 - $54,721	-424 Reduced 0.37%	113,875 $13.5 Million
Q2 2021 Jul 28, 2021	SELL	$105.79 - $124.53 $271,351 - $319,419	-2,565 Reduced 2.19%	114,299 $13.3 Million
Q1 2021 Apr 22, 2021	SELL	$108.84 - $128.23 $41,359 - $48,727	-380 Reduced 0.32%	116,864 $14 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $198,450 - $216,253	-1,890 Reduced 1.59%	117,244 $12.8 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $32,532 - $39,507	355 Added 0.3%	119,134 $13 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $323,508 - $414,050	-4,225 Reduced 3.43%	118,779 $10.9 Million
Q1 2020 May 04, 2020	SELL	$62.82 - $91.86 $67,217 - $98,290	-1,070 Reduced 0.86%	123,004 $9.71 Million
Q4 2019 Jan 28, 2020	BUY	$78.51 - $87.4 $24,887 - $27,705	317 Added 0.26%	124,074 $10.8 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $149,112 - $161,684	-1,822 Reduced 1.45%	123,757 $10.4 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $267,834 - $312,375	-3,675 Reduced 2.84%	125,579 $10.6 Million
Q1 2019 May 07, 2019	SELL	$66.22 - $80.06 $144,359 - $174,530	-2,180 Reduced 1.66%	129,254 $10.3 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $262,895 - $297,822	-4,010 Reduced 2.96%	131,434 $9.51 Million
Q3 2018 Oct 30, 2018	SELL	$60.81 - $73.36 $60,810 - $73,360	-1,000 Reduced 0.73%	135,444 $9.94 Million
Q2 2018 Aug 01, 2018	SELL	$57.57 - $63.54 $29,936 - $33,040	-520 Reduced 0.38%	136,444 $8.32 Million
Q1 2018 May 01, 2018	BUY	$56.27 - $63.62 $22,226 - $25,129	395 Added 0.29%	136,964 $8.21 Million
Q4 2017 Jan 30, 2018	SELL	$53.68 - $57.47 $128,724 - $137,813	-2,398 Reduced 1.73%	136,569 $7.79 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $79,395 - $88,613	1,652 Added 1.2%	138,967 $7.42 Million
Q2 2017 Aug 07, 2017	BUY	N/A	137,315	137,315 $6.68 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ramsay, Stattman, Vela & Price, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ramsay, Stattman, Vela & Price, Inc. with notifications on news.

Account

Ramsay, Stattman, Vela & Price, Inc. Abbott Laboratories Transaction History